TNFSF10 and acute myeloid leukemia: These findings suggest that a potent therapeutic strategy for the treatment of AML can be achieved by administering HHT at low doses in conjunction with SAHA by controlling the production of TRAIL and activation of the TRAIL apoptotic pathway.